Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of AC102 versus steroids in adults with idiopathic sudden sensorineural hearing loss. The study is currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AC102

Snippet

Sponsor: AudioCure Pharma GmbH | Conditions: Hearing Loss, Sensorineural | Phase 2 | Status: ACTIVE_NOT_RECRUITING